Microtesla Magnetic Therapy (MMT) Treatment of Cognitive Impairment: Open Label Pilot Study
Icahn School of Medicine at Mount Sinai
Summary
The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.
Eligibility
- Age range
- 16+ years
- Sex
- All
- Healthy volunteers
- No
IncInclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Any sex/gender * 16 years of age or older * English Speaking * Experiencing symptoms of at least self-reported mild cognitive impairment associated with a confirmed diagnosis of a condition such as Long COVID, Traumatic Brain Injury, other Acquired Brain Injuries, and other neurodegenerative diagnoses including but not limited to Alzheimer's disease * Individuals of childbearing age agreeing to use a highly effective form of birth control for the duration of t…
Interventions
- DeviceFareon device
Participants will use the device 2 times per week for 15 minutes at home.
Location
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)New York, New York